Global Mycoplasma Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150549
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.

Scope of the Report:

This report studies the Mycoplasma Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mycoplasma Diagnostics market by product type and applications/end industries.

Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.

The global Mycoplasma Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mycoplasma Diagnostics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Agilent Technologies, Inc

Thermo Fisher Scientific Inc

PromoCell GmbH

Charles River Laboratories International, Inc

Merck KGaA

Lonza Group

Takara Bio Inc (Takara Holding Company Inc.)

Savyon Diagnostics

Tecan Trading AG (Tecan Group)

Sartorius Stedim BioOutsource Limited

American Type Culture Collection (ATCC)

F Hoffmann-La Roche

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Kits & Reagents

Instruments

Software & Services

Market Segment by Applications, can be divided into

Hospitals

Diagnostic Laboratories

Clinics

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Mycoplasma Diagnostics Market Overview

1.1 Product Overview and Scope of Mycoplasma Diagnostics

1.2 Classification of Mycoplasma Diagnostics by Types

1.2.1 Global Mycoplasma Diagnostics Revenue Comparison by Types (2017-2023)

1.2.2 Global Mycoplasma Diagnostics Revenue Market Share by Types in 2017

1.2.3 Kits & Reagents

1.2.4 Instruments

1.2.5 Software & Services

1.3 Global Mycoplasma Diagnostics Market by Application

1.3.1 Global Mycoplasma Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Clinics

1.3.5 Others

1.4 Global Mycoplasma Diagnostics Market by Regions

1.4.1 Global Mycoplasma Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Mycoplasma Diagnostics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Mycoplasma Diagnostics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mycoplasma Diagnostics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Mycoplasma Diagnostics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mycoplasma Diagnostics Status and Prospect (2013-2023)

1.5 Global Market Size of Mycoplasma Diagnostics (2013-2023)

2 Manufacturers Profiles

2.1 Agilent Technologies, Inc

2.1.1 Business Overview

2.1.2 Mycoplasma Diagnostics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Agilent Technologies, Inc Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Thermo Fisher Scientific Inc

2.2.1 Business Overview

2.2.2 Mycoplasma Diagnostics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Thermo Fisher Scientific Inc Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.3 PromoCell GmbH

2.3.1 Business Overview

2.3.2 Mycoplasma Diagnostics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 PromoCell GmbH Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Charles River Laboratories International, Inc

2.4.1 Business Overview

2.4.2 Mycoplasma Diagnostics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Charles River Laboratories International, Inc Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Merck KGaA

2.5.1 Business Overview

2.5.2 Mycoplasma Diagnostics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Merck KGaA Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Lonza Group

2.6.1 Business Overview

2.6.2 Mycoplasma Diagnostics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Lonza Group Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.7 Takara Bio Inc (Takara Holding Company Inc.)

2.7.1 Business Overview

2.7.2 Mycoplasma Diagnostics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.8 Savyon Diagnostics

2.8.1 Business Overview

2.8.2 Mycoplasma Diagnostics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Savyon Diagnostics Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Tecan Trading AG (Tecan Group)

2.9.1 Business Overview

2.9.2 Mycoplasma Diagnostics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.10 Sartorius Stedim BioOutsource Limited

2.10.1 Business Overview

2.10.2 Mycoplasma Diagnostics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.11 American Type Culture Collection (ATCC)

2.11.1 Business Overview

2.11.2 Mycoplasma Diagnostics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.12 F Hoffmann-La Roche

2.12.1 Business Overview

2.12.2 Mycoplasma Diagnostics Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Mycoplasma Diagnostics Market Competition, by Players

3.1 Global Mycoplasma Diagnostics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Mycoplasma Diagnostics Players Market Share

3.2.2 Top 10 Mycoplasma Diagnostics Players Market Share

3.3 Market Competition Trend

4 Global Mycoplasma Diagnostics Market Size by Regions

4.1 Global Mycoplasma Diagnostics Revenue and Market Share by Regions

4.2 North America Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

4.3 Europe Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

4.5 South America Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

5 North America Mycoplasma Diagnostics Revenue by Countries

5.1 North America Mycoplasma Diagnostics Revenue by Countries (2013-2018)

5.2 USA Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

5.3 Canada Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

5.4 Mexico Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

6 Europe Mycoplasma Diagnostics Revenue by Countries

6.1 Europe Mycoplasma Diagnostics Revenue by Countries (2013-2018)

6.2 Germany Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

6.3 UK Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

6.4 France Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

6.5 Russia Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

6.6 Italy Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Mycoplasma Diagnostics Revenue by Countries

7.1 Asia-Pacific Mycoplasma Diagnostics Revenue by Countries (2013-2018)

7.2 China Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

7.3 Japan Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

7.4 Korea Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

7.5 India Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

8 South America Mycoplasma Diagnostics Revenue by Countries

8.1 South America Mycoplasma Diagnostics Revenue by Countries (2013-2018)

8.2 Brazil Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

8.3 Argentina Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

8.4 Colombia Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Mycoplasma Diagnostics by Countries

9.1 Middle East and Africa Mycoplasma Diagnostics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

9.3 UAE Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

9.4 Egypt Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

9.6 South Africa Mycoplasma Diagnostics Revenue and Growth Rate (2013-2018)

10 Global Mycoplasma Diagnostics Market Segment by Type

10.1 Global Mycoplasma Diagnostics Revenue and Market Share by Type (2013-2018)

10.2 Global Mycoplasma Diagnostics Market Forecast by Type (2018-2023)

10.3 Kits & Reagents Revenue Growth Rate (2013-2023)

10.4 Instruments Revenue Growth Rate (2013-2023)

10.5 Software & Services Revenue Growth Rate (2013-2023)

11 Global Mycoplasma Diagnostics Market Segment by Application

11.1 Global Mycoplasma Diagnostics Revenue Market Share by Application (2013-2018)

11.2 Mycoplasma Diagnostics Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Diagnostic Laboratories Revenue Growth (2013-2018)

11.5 Clinics Revenue Growth (2013-2018)

11.6 Others Revenue Growth (2013-2018)

12 Global Mycoplasma Diagnostics Market Size Forecast (2018-2023)

12.1 Global Mycoplasma Diagnostics Market Size Forecast (2018-2023)

12.2 Global Mycoplasma Diagnostics Market Forecast by Regions (2018-2023)

12.3 North America Mycoplasma Diagnostics Revenue Market Forecast (2018-2023)

12.4 Europe Mycoplasma Diagnostics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Mycoplasma Diagnostics Revenue Market Forecast (2018-2023)

12.6 South America Mycoplasma Diagnostics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Mycoplasma Diagnostics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Mycoplasma Diagnostics Picture

Table Product Specifications of Mycoplasma Diagnostics

Table Global Mycoplasma Diagnostics and Revenue (Million USD) Market Split by P

Please fill the form below, to recieve the report sample


+1